A phase 2, randomized, placebo-controlled, double-blind, ascending dose study to evaluate efficacy, safety, tolerability, pharmacokinetics, pharmacodynamics & pharmacogenetics of CC-220 in subjects with SLE

被引：0
|
作者：
Werth, V. [1 ]
Furie, R. [2 ]
Hough, D. [3 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azarian, A. [3 ]
Schafer, P. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
机构：
[1] UPenn, Philadelphia, PA USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene, Summit, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 05期
关键词：
D O I：
10.1016/j.jid.2017.02.396
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
379
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [21] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [22] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants
    Li, Yunfei
    Zhang, Hua
    Pandya, Hitesh
    Miao, Liyan
    Reid, Fred
    Jimenez, Eulalia
    Sadiq, Muhammad Waqas
    Moate, Rachel
    Lei, Alejhandra
    Zhou, Xiao-Hong
    Kell, Chris
    Ding, Junjie
    Zhang, Guanlin
    Zhao, Lina
    Ge, Xiaoyun
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (06): : 665 - 671
  • [23] A Randomized, Double-Blind, Placebo-Controlled, Single-Centre, Single Ascending Dose And Multiple Ascending Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Molgramostim (rhgm-Csf) Administered By Inhalation To Healthy Adult Subjects
    Tarnow, I.
    Nymark, K.
    Vinge, M.
    Nielsen, K. A.
    Ganslandt, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [24] A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects
    Leubitz, Andi
    Vanhoutte, Frederic
    Hu, Ming-yi
    Porter, Kaela
    Gordon, Efrat
    Tencer, Kathleen
    Campbell, Kathleen
    Banks, Kate
    Haverty, Tom
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (08): : 859 - 869
  • [25] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Lesley Taylor
    Barry Gidal
    Graham Blakey
    Bola Tayo
    Gilmour Morrison
    CNS Drugs, 2018, 32 : 1053 - 1067
  • [26] A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    Taylor, Lesley
    Gidal, Barry
    Blakey, Graham
    Tayo, Bola
    Morrison, Gilmour
    CNS DRUGS, 2018, 32 (11) : 1053 - 1067
  • [27] A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS
    Jochelson, P.
    van de Wetering, J. L.
    Bornstein, J.
    Resler, M.
    Anderson, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S70 - S70
  • [28] First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
    Shen, Qi
    Hu, Chao
    Miao, Jia
    Chen, Junxia
    Peng, Yueying
    Pan, Tingting
    He, Xiaolin
    Yuan, Jing
    Ni, Shaonan
    Wang, Yongsheng
    Luo, Zhu
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 159
  • [29] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
    Huang, Kai
    Ding, Ying
    Que, Linling
    Chu, Nannan
    Shi, Yunfei
    Qian, Zhenzhong
    Qin, Wei
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Zhiwei
    Xu, Jianguo
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Moderate to Severe Asthma
    Busse, William W.
    Holgate, Stephen T.
    Kerwin, Edward M.
    Chon, Yun
    Feng, JingYuan
    Lin, Joseph H.
    Lin, Shao-Lee
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB230 - AB230
12345